KN
Koteshwar Narasimhachar Sridhar
About Koteshwar Narasimhachar Sridhar
Data last updated:
Koteshwar Narasimhachar Sridhar was a Director at Sri Research For Tissue Engineering Private Limited (2009–2021), Director at Cancyte Technologies Private Limited (2013–2021) and Director at Arkin Life Sciences Private Limited (from 2016). The companies operate in Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Apr 2009 | 2009 | ₹17,524 (FY 2023) | Active | |
| Director | 28 Feb 2013 | 2013 | ₹1.50 Cr (FY 2025) | Active | |
| Director | 02 Feb 2016 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Koteshwar Narasimhachar Sridhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Koteshwar Narasimhachar Sridhar
Koteshwar Narasimhachar Sridhar was first appointed on 30 Apr 2009 as Director at Sri Research For Tissue Engineering Private Limited. The most recent appointment on record is 02 Feb 2016 at Arkin Life Sciences Private Limited.
Koteshwar Narasimhachar Sridhar held 3 earlier board appointments: Sri Research For Tissue Engineering Private Limited (Director, 30 Apr 2009 to 16 Nov 2021); Cancyte Technologies Private Limited (Director, 28 Feb 2013 to 16 Nov 2021); Arkin Life Sciences Private Limited (Director, from 02 Feb 2016).